Table 6.
IBQ | 12 months | |||||
---|---|---|---|---|---|---|
N | scale 1 (stress) |
scale 2 (smiling and laughter) |
scale 3 (distress to limitations) |
scale 4 (activity) |
scale 5 (duration of orienting) |
|
Sum PCB ng/g lipid | T = 96 | −.081 | −.164 | .014 | .047 | −0.125 |
Girls | ♀ = 44 | NS | NS | NS | NS | NS |
Boys | ♂ = 52 | NS | NS | NS | NS | NS |
Calux-TEQ pg/g lipid | T = 68 | −.247* | .117 | .048 | .119 | .085 |
Girls | ♀ = 37 | NS | NS | NS | NS | 0.468** |
Boys | ♂ = 31 | NS | NS | NS | NS | NS |
PCB-118 ng/g lipid | T = 95 | −.092 | .007 | −.201* | −.131 | −.061 |
Girls | ♀ = 51 | NS | NS | NS | NS | NS |
Boys | ♂ = 44 | NS | NS | --0.379* | NS | NS |
PCB-170 ng/g lipid | T = 95 | .007 | .187 | −.103 | −.054 | −.083 |
Girls | ♀ = 51 | NS | NS | NS | NS | NS |
Boys | ♂ = 44 | NS | NS | NS | NS | NS |
HCB ng/g lipid | T = 93 | −.150 | .193* | −.022 | .045 | .182 |
Girls | ♀ = 50 | NS | NS | NS | NS | 0.343* |
Boys | ♂ = 43 | NS | 0.386* | NS | NS | NS |
DDE ng/g lipid | T = 100 | −.201* | .071 | −.147 | .103 | −.158 |
Girls | ♀ = 54 | −0.299* | NS | NS | NS | −0.308* |
Boys | ♂ = 46 | NS | 0.347* | NS | NS | NS |
Sum PCB*HCB | T = 93 | −.079 | −.046 | −.048 | −.034 | .031 |
Girls | ♀ = 50 | NS | NS | NS | NS | NS |
Boys | ♂ = 43 | NS | NS | NS | NS | NS |
Sum PCB*DDE | T = 96 | .026 | .078 | .054 | .159 | .078 |
Girls | ♀ = 52 | NS | NS | NS | NS | NS |
Boys | ♂ = 44 | NS | 0.376* | NS | NS | NS |
IBQ and IBQ scales: see overview tests in Table 1
PCBs, Calux-TEQ, DDE, HCB: see blood sampling and measurements
Su PCB*HCB, sum PCB*DDE: see statistical analysis
* = 0.050 ≤ p < 0.10, ** = 0.010 ≤ p < 0.050, *** = 0.001 ≤ p < 0.010